Quantitative Research

A-H Premium Weekly (Sep 11th): Minsheng Bank, Innocare Pharma, Yofc, Citic Sec

11 Sep 2026 By Ke Yan, CFA
← All Research Reports

Abstract: We analyzed A-H premium changes across 196 dual-listed China stocks for the week ending September 11th, with the average A-H premium at 83.5%, up 1.7 percentage points week-on-week. The premium expansion was broad, with 121 stocks increasing versus 75 decreasing. Real Estate led sector gains at +3.8ppt while Health Care posted the largest sector decline at -0.9ppt. The top premium wideners were Drinda (+54.9ppt), Chenming Paper (+37.6ppt), Triumph New Energy (+35.3ppt), and Yofc (+23.9ppt), and the top narrowers were Fudanzhangjiang (-19.9ppt), Comec (-16.3ppt), Mabwell (-15.6ppt), and Innocare Pharma (-13.6ppt). Minsheng Bank reached a 52-week A-H premium high at 23.1% (+7.7ppt, z-score 3.0) and Citic Sec also hit a 52-week high at 23.2% (+4.8ppt).

INNOCARE PHARMA (9969 HK) CITIC SEC (6030 HK) MINSHENG BANK (1988 HK) YOFC (6869 HK)

Highlighted Stocks

INNOCARE PHARMA, CITIC SEC, MINSHENG BANK, YOFC

Interested in the full report? Get in touch with our team.